Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Comparative Study of the Effect of Dapagliflozin Versus Empagliflozin ,Added to Metformin, on NAFLD in Patients With Type 2 Diabetes

NCT07363707 is registered in ClinicalTrials.gov with Beni-Suef University as lead sponsor.

NCT NCT07363707
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07363707 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Comparative Study of the Effect of Dapagliflozin Versus Empagliflozin ,Added to Metformin, on NAFLD in Patients With Type 2 Diabetes
Lead sponsor
Beni-Suef University
Phase
Phase 4
Overall status
Completed
Start date
May 1, 2023
Completion date
March 1, 2024
Enrollment
108 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nafld (nonalcoholic fatty liver disease)